Table 1.
Patient descriptors and medication use
| Age | 48 ± 12 yr (18–79; n = 440) |
| Gender | 59% (322 men) |
| Cadaver | 66% (355 cadaver) |
| Creatinine | 152 ± 65 μmol/l |
| CrCl | 61 ± 24 ml/min |
| Duration of function | 6.3 ± 6.6 yr |
| Duration of dialysis | 1.4 ± 1.8 yr |
| Body mass index | 28.6 ± 6.4 kg/m2 |
| Weight (kg) 0.5 to 31.3 yr | 81 ± 19 kg |
| Immunosuppression | |
| Cyclosporine | 51% |
| Tacrolimus | 36% |
| Mycophenolate mofetil | 38% |
| Azathioprine | 13% |
| Sirolimus | 13% |
| Prednisone | 81% |
| CVD drug use | |
| ACEi/ARB | 43% |
| β-blocker | 49% |
| Statin | 50% |
| ASA/other | 32% |
CrCl, creatinine clearance by Cockcroft-Gault; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; statin, HMG CoA reductase inhibitor; ASA, acetylsalicylic acid.